Canada markets closed

CARGO Therapeutics, Inc. (CRGX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.00-1.38 (-6.77%)
At close: 04:00PM EDT
19.00 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 802.33M
Enterprise Value 425.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.98
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.58

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 338.73%
S&P500 52-Week Change 325.59%
52 Week High 333.92
52 Week Low 313.14
50-Day Moving Average 323.11
200-Day Moving Average 321.12

Share Statistics

Avg Vol (3 month) 3313.23k
Avg Vol (10 day) 3140.23k
Shares Outstanding 539.37M
Implied Shares Outstanding 642.22M
Float 819.63M
% Held by Insiders 17.59%
% Held by Institutions 199.37%
Shares Short (Apr 15, 2024) 43.4M
Short Ratio (Apr 15, 2024) 47.77
Short % of Float (Apr 15, 2024) 410.28%
Short % of Shares Outstanding (Apr 15, 2024) 48.63%
Shares Short (prior month Mar 15, 2024) 42.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.09%
Return on Equity (ttm)-53.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -95.22M
Net Income Avi to Common (ttm)-98.15M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)405.73M
Total Cash Per Share (mrq)10.31
Total Debt (mrq)28.54M
Total Debt/Equity (mrq)7.04%
Current Ratio (mrq)19.35
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-81.16M
Levered Free Cash Flow (ttm)-68.1M